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Abstract – The objective of this work was to evaluate the effects of supplementation with melengestrol acetate 
(MGA), after timed artificial insemination (TAI), on the conception rate of Nellore cows, according to cyclicity 
during the protocol, estrus expression between intravaginal device withdrawal and insemination, and diameter 
of the largest follicle at the time of insemination, in order to identify predictors of the use of MGA. Multiparous 
lactating cows (577) were subjected to a hormonal protocol for ovulation synchronization. On day -2 of the 
protocol, the animals were painted with a marker on the base of their tail. On day 0, they were evaluated 
for estrus expression; the preovulatory follicle diameter (POFD) was measured by ultrasonography, and the 
artificial insemination was performed. The animals were assigned to two experimental groups according to 
the supplementation or not with 0.50 mg MGA, between 13 and 18 days after TAI. Pregnancy diagnosis was 
performed using an ultrasound examination 35 days after TAI. A positive effect of the treatment with MGA 
on the conception rate occurred generally in animals in anestrus, irrespective of the estrus expression. For 
animals treated with MGA, only those with POFD greater than 14 mm showed better conception rates that 
the control group.
Index terms: anestrous, bovine, fertility, insemination, melengestrol acetate.
Suplementação com progesterona oral para gado de corte 
após a inseminação em programas de IATF 
Resumo – O objetivo deste trabalho foi avaliar o efeito da suplementação com acetato de melengestrol (MGA), 
após a inseminação artificial em tempo fixo (IATF), sobre a taxa de concepção de fêmeas bovinas da raça 
Nelore, de acordo com a ciclicidade durante o protocolo, a expressão do estro entre a retirada do dispositivo 
intravaginal e a inseminação, e o diâmetro do maior folículo no momento da inseminação, para determinar 
preditores da utilização do MGA. Fêmeas multíparas lactantes (577) foram submetidas a um protocolo 
hormonal de sincronização da ovulação. No dia -2 do protocolo, foram pintadas com bastão marcador na base 
da cauda. No dia 0, foram avaliadas em relação à expressão do estro; a mensuração do diâmetro do folículo 
pré-ovulatório (DFOL) foi feita por ultrassonografia, e a inseminação artificial foi realizada. Os animais 
foram distribuídos em dois grupos experimentais de acordo com a suplementação ou não com 0,50 mg de 
MGA entre 13 e 18 dias após IATF. O diagnóstico de gestação foi realizado por exame ultrassonográfico 35 
dias após IATF. Um efeito positivo do tratamento com MGA sobre a taxa de concepção ocorreu, em geral, 
nos animais em anestro, independentemente da expressão do estro. Nos animais tratados com MGA, apenas 
os com DFOL acima de 14 mm apresentaram melhores taxas de concepção que o grupo-controle.
Termos para indexação: anestro, bovino, fertilidade, inseminação, acetato de melengestrol.
Introduction
Reproductive efficiency is the most influential factor 
in the productivity and profitability of beef cattle 
ranching (Baruselli, 2016). However, despite high-
fertilization rates (90 to 95%) in fixed-time artificial 
insemination programs (TAI), 29 to 39% of embryos do 
not develop to term, which negatively impacts the final 
results of the breeding seasons (Wiltbank et al., 2016).
These losses in the early stages of gestation 
are a reflection of the complexity of the embryo 
preimplantation period, which includes the interval 
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between oocyte fertilization and implantation of the 
conceptus (Diskin et al., 2011). In this gestational 
stage, the glandular epithelium of the endometrium is 
stimulated to proliferate and produce substrates, amino 
acids, and growth factors, among other histotrophic 
secretions (uterine milk) that will nourish the embryo 
until the moment of implantation. These secretions 
correspond to the first source of available nutrients to 
the conceptus and are produced under progesterone 
(P4) stimulation (Forde et al., 2009).
Low-circulating concentrations of P4 during the 
post-ovulatory period were associated with smaller 
embryos on day 16 and with a lower-secretion of 
interferon-tau (IFN-τ), when it was ineffective at 
blocking the luteolytic process and maintaining 
pregnancy (Mann & Lamming, 2001). However, 
the increase of their concentrations after TAI was 
associated with alterations in the expression of 
endometrial genes (Forde et al., 2009), which led to 
the progressive elongation of the conceptus, as well as 
to an increase in IFN-τ production (Carter et al., 2008) 
and higher-pregnancy rates in beef cows (Diskin & 
Morris, 2008).
From this perspective, many studies have sought 
strategies to improve the plasma concentrations of 
P4 after insemination and, consequently, increase 
the fertility rates in TAI programs. Some of these 
strategies are the use of hCG, GnRH, or their analogs 
to facilitate the formation of an accessory corpus 
luteum and the supplementation with diverse sources 
of P4 (oral, injectable, intravaginal or auricular) 
(Loiola et al., 2014; Monteiro Jr. et al., 2015). Among 
the sources of progesterone available in the market, 
melengestrol acetate (MGA) stands out for being 
a synthetic progestational steroid that is orally 
administered, therefore it is convenient and does not 
require additional herd management for administration 
(Perez, 2005).
Increasing the plasma levels of P4 has been a 
success achieved by most researchers. However, when 
assessing the effects on fertility improvement, the 
results are quite inconsistent and have shown positive, 
negative, or noninterfering effects on conception rates 
(Yan et al., 2016).
Among the reasons for the discrepancies in 
the obtained results, it is possible to highlight the 
evaluation of the general conception rate in most of 
these studies that did not consider the variety of factors 
in the same group of females, which may affect the 
plasma concentrations of P4 at the onset of pregnancy 
differently. There may be a need for the exogenous 
support of this hormone within the same group of 
treated animals (Pugliesi et al., 2016).
To minimize the effects of these factors as to 
treatment with MGA on the conception rate, and due 
to the scarcity of such data in the literature, the effects 
of the treatment with P4 should be evaluated according 
to the following variables: ovarian cyclicity during the 
protocol, estrus expression, and diameter of the largest 
follicle at the time of TAI. We sought to confirm the 
hypothesis that treatment with MGA acts differently 
on each of these variables to improve the conception 
rate, especially in animals that have impaired fertility 
from a deficiency of follicular or luteal function, as 
described by Yan et al. (2016) after several studies on 
P4 supplementation.
The objective of this work was to evaluate the 
effects of supplementation with melengestrol acetate 
(MGA) after timed artificial insemination (TAI), on 
the conception rate of Nellore cows, according to the 
cyclicity during the protocol, the estrus expression 
between intravaginal device withdrawal and 
insemination, and the diameter of the largest follicle at 
the time of insemination, in order to identify predictors 
of MGA use.
Materials and Methods
The experiment was carried out from October to 
December 2015, on a commercial farm located in the 
region of Recôncavo Baiano (12º21'11"S, 38º22'44"W), 
Bahia state, Brazil. The region has an average annual 
rainfall of 1,400 mm, and it is inserted in a humid 
tropical climate area whose predominant vegetation is 
the Atlantic Forest.
Multiparous lactating Nellore cows (Bos indicus), in 
a total of 577 animals of 6.74±3.25 years of age, a body 
condition score (BSC) of 3.29±0.48, on a scale from 1 
to 5 (Ayres et al., 2009), and 31 to 58 days postpartum, 
were used. All animals were kept in paddocks, in 
a predominant pasture of Urochloa decumbens 
(Syn. Brachiaria decumbens), and received mineral 
supplementation and water ad libitum.
Before the beginning of synchronization, the animals 
underwent a gynecological examination by transrectal 
ultrasonography with a linear transducer of 6.0 MHz 
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frequency (Mindray, DP 2200 VET, São Paulo, SP, 
Brazil). Females that did not show reproductive tract 
abnormalities during the evaluation were considered 
eligible to participate in the experiment. To evaluate 
the ovarian cyclicity, this exam was repeated on the 
8th day of the protocol: females that did not show 
luteal tissue in either of the gynecological exams were 
considered in anestrus, and those that showed luteal 
tissue in at least one of the exams were considered to 
be cycling.
The animals were subjected to the following 
synchronization protocol (Figure 1): on a random day 
of the estrous cycle (D-10) they received an intravaginal 
P4 device (1 g, DIB, Zoetis, São Paulo, SP, Brazil), 
and 2 mg of estradiol benzoate was administered 
intramuscularly (IM) (Gonadiol, Zoetis, São Paulo, SP, 
Brazil). On day -2 (D-2), the intravaginal device of P4 
was removed, and 12.5 mg of dinoprost tromethamine 
(IM) was administered (Lutalyse, Zoetis, São Paulo, 
SP, Brazil), followed by 1.0 mg of estradiol cypionate 
(IM) (ECP, Zoetis, São Paulo, SP, Brazil), and 300 IU of 
eCG (IM) (Novormon, Zoetis, São Paulo, SP, Brazil). 
After removing the intravaginal device, the animals 
were painted with a marker stick (RAIDEX, GmbH, 
Dettingen/Erms, Germany) on the base of their tail to 
detect estrus. On day 0 (D-0), the inseminations were 
performed from 48 to 54 hours after removing the P4 
devices, using cryopreserved semen from five Nellore 
bulls with established fertility. At the time of TAI, 
semen was thawed at 37°C for 30 s, and all procedures 
were performed by the same technician.
Before performing the TAI, the measurement of 
the largest follicle (POFD) was carried out using 
transrectal ultrasonography and a linear transducer 
with a 6 MHz frequency (Mindray, DP 2200 VET, São 
Paulo, SP, Brazil). The POFD was calculated from the 
mean of the two largest axes forming an angle of 90° 
between them, and categorized as <11 mm, 11 to 14 
mm, or >14 mm. The expression of estrus or the lack 
of it was checked according to the status of the paint, at 
the base of the tail, at the time of insemination.
All procedures were performed in batches of up 
to 100 cows and repeated throughout the experiment 
for all of the evaluated animals. During TAI, each 
batch of animals subjected to treatment was randomly 
split into two experimental groups, according to 
supplementation with an exogenous source of P4. In the 
treatment with the use of MGA, the animals received 
supplements for 6 days – from the 13th to the 18th day 
after TAI –, with 0.50 mg of MGA, which corresponds 
to 2.28 g per animal per day of MGA Premix (MGA), 
provided in the feeding trough along with mineral salt. 
Figure 1. Diagram of the experimental design. BSC, body score condition; USG, ultrasonography; EB, estradiol benzoate; 
P4, progesterone from the device; EC, estradiol cypionate; eCG, equine chorionic gonadotropin; PGF2α, prostraglandin F2α; 
POFD, preovulatory follicle diameter; MGA, melengestrol acetate; and PD, pregnancy diagnosis.
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In the treatments without MGA, the animals received 
the same type of mineral salt. These animals were 
managed under the same conditions as the treated 
group. To make the treated animals consume feed 
more homogeneously at each round of insemination, 
the treated group had a maximum of 50 animals.
The mineral supplement was provided according to 
the methods of Rodrigues et al. (2014), and the trough 
was assessed daily from the eighth day of insemination, 
in order to observe and record consumption in the 
morning and afternoon. The leftovers were weighed, 
if necessary, and the amount required per batch per 
day was adjusted, such that when the treatment with 
MGA started, the exact average of mineral salt intake 
per animal had already been defined for each batch. 
The amount of MGA corresponding to the daily 
consumption of the batch was added to the daily amount 
of mineral salt. To verify the MGA intake, the trough 
was also assessed every day, in the morning and in the 
afternoon, during treatment. From the nineteenth day 
onwards, MGA consumption was interrupted, and the 
animals from both groups started to consume mineral 
salt only.
Pregnancy was diagnosed by transrectal ultrasono-
graphy 35 days after insemination, and the conception 
rate was calculated by dividing the total number of 
pregnant cows by the total number of inseminated ones.
The information was analyzed using multivariate 
logistic regression in the Statistical Package for 
Social Science (SPSS), version 19 (IBM Corporation, 
Armonk, NY, USA), at 5%, probability. To analyze 
the conception rate after TAI of all animals in the 
initial model, the following elements were included: 
effect of age postpartum; number of insemination 
rounds; ECC; ovarian cyclicity at the beginning of the 
protocol; diameter of the largest follicle at the time 
of insemination (POFD <11 mm, 11 to 14 mm, or 
>14 mm); bull used for the insemination; expression 
or lack of expression of estrus between the removal 
of the intravaginal device and insemination; and 
supplementation with MGA from the 13th to the 18th 
day after TAI. Subsequently, the conception rates 
were compared between the experimental groups by 
applying a frequency dispersion study using the chi-
square test. In the first phase of the analyses, only 
the MGA treatment groups (with MGA, n=327, and 
without MGA, n=250) were considered. In the second 
step, the interaction of the following variables was 
compared: cyclicity during the protocol, diameter of 
the largest follicle at the time of insemination, and 
expression or lack thereof for estrus between the 
removal of the intravaginal device and insemination, 
along with MGA treatment or the control treatment.
Results and Discussion
There were no effects of postnatal age, insemination 
rounds, body score condition, or the bull used for 
insemination, on the conception rates. In the present 
study, the average conception rate was 53.21% 
(307/577), which is similar to the rate observed by 
several authors who worked with beef cows (Bos 
indicus) in TAI programs (Ribeiro Filho et al., 2013; 
Rodrigues et al., 2014). In addition, a positive effect 
of the treatment with MGA was observed – between 
the 13th and 18th day after TAI – on the conception rate 
of the animals that received MGA (58.41%), compared 
with that of the animals without supplementation with 
MGA (46.40%) (Table 1). However, the individual 
factors, such as ovarian cyclicity at the beginning of 
the protocol, the diameter of the largest follicle at the 
time of insemination, and the expression or lack of 
expression for estrus between the withdrawal of the 
intravaginal device and insemination, affected the 
conception rate after TAI.
The MGA improvement of the conception rate 
in this period is justified, as it improved the uterine 
environment and stimulated the embryo during fetal-
maternal signaling, which promoted gestation, as 
described by Silva Junior et al. (2014). According to 
these authors, multiparous Nellore cows achieved 
higher-pregnancy rates  by the treatment with MGA 
between the 13th and the 17th day after the TAI protocol, 
which is a similar outcome to the results of the current 
study. In contrast, Rodrigues et al. (2014) evaluated the 
Table 1. Conception rates for Nellore cows subjected to TAI 
program, treated or not with 0.5 mg per day of melengestrol 
acetate (MGA)(1)
Treatment Number of animals Conception rate (%)
With MGA 327 58.41a
Without MGA 250 46.40b
Total 577 53.21
(1)Values followed by the same letter do not differ by chi-square test, at 5% 
probability. The supplementation with MGA was done between 13 and 18 
days after insemination.
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effects of progesterone supplementation on fertility in 
Nellore cows by providing 2.28 g of MGA between the 
13th and 18th days after insemination, and no significant 
difference in the conception rates of the treated 
animals (50.00%) was observed, in comparison with 
the control group (42.16%). 
The variation of the results obtained with P4 
supplementation after TAI can be justified by the 
fact that ovarian function affects the circulating 
level of progesterone at the time of supplementation. 
Further, for animals that have low-progesterone serum 
levels, supplementation may be beneficial, whereas 
for animals that show adequate progesterone serum 
levels, the supplementation will not show any benefit, 
which highlights the need for the evaluation of the 
ovarian condition to establish an appropriate strategy 
(Rodrigues et al., 2014).
According to previous studies, several factors may 
affect the conception rates of animals supplemented 
with P4, and this complexity can be noted in the 
experiments of Larson et al. (2009), who found positive 
effects on fertility, when dairy cows were supplemented 
with a progesterone intravaginal device; however, 
these authors found no improvement in beef cows that 
received the same treatment, at the same time, which 
suggested that there was a difference in response to 
treatment according to the type of animal that was 
treated (beef or dairy). Stevenson and Lamb (2016) 
proposed that physiological differences, including 
the circulating concentrations of progesterone and 
responses to supplemental progesterone, affected 
by the genotype and nutritional management of the 
animals, could account for the variation.
The timing of supplementation with P4 is another 
important factor for embryo survival, and it was 
studied by Yan et al. (2016) in a meta-analysis that 
evaluated P4 supplementation provided via injection 
or intravaginal administration in beef and dairy 
cows. These authors observed a beneficial effect of 
supplementation only when it was performed in the 
first week post-insemination, but no benefit was seen 
when supplementation was provided early (< 3 days 
after artificial insemination, AI), or during the second 
or third week. In contrast, a satisfactory effect on the 
conception rate was found in the current study, in 
which supplementation with MGA occurred between 
days 13 and 18 after insemination. This result suggests 
that the progestogen type that was used (MGA) could 
justify these findings, as also could the period of 
supplementation. 
Rodrigues et al. (2014) believed that providing 
this progestogen, in the first week after TAI, reduced 
conception rates in beef cows due to its mode of action, 
and promoted an inadequate endocrine environment. 
This may have been due to changes in uterine pH or to 
another factor that could make the embryonic growth 
and development nonviable in this period, according 
to Silva et al. (2015), who also observed a reduction 
in the conception rate in cows that received the same 
treatment in a similar period.
When the interaction of treatment with the cyclicity 
was evaluated, the effects of the supplementation with 
MGA could only be observed in the animals that were 
in anestrous (Table 2). Thus, the proposed hypothesis 
was supported, which indicates that there was a 
possible impairment in fertility, and a greater need for 
exogenous P4 support for females that were cycling.
According to previous studies, beef and dairy 
cows in postnatal anestrus, at the beginning of the 
TAI programs, had smaller follicles, which resulted 
in smaller or less functional CLs in relation to the 
production of P4 (Macmillan et al., 2003; Barreiros 
et al., 2014), thus justifying the better response of 
animals in anestrus at the beginning of the protocol, 
after the supplementation with MGA, in comparison 
with cycling animals.
This information was reinforced by Baruselli et al. 
(2004), who evaluated the conception rates according 
to the structures identified in the ovaries, during the 
gynecological exam prior to conducting the protocol 
for Nellore cows in TAI programs. According to 
these authors, the animals that had corpus luteum at 
Table 2. Conception rate and cyclicity of Nellore cows 
subjected to a TAI protocol, with and without the use of 0.5 
mg per day of melengestrol acetate (MGA)(1).
Treatment Number of animals Conception rate (%)
Cycling cows
With MGA 130 61.54a
Without MGA 75 58.67a
Anestrus
With MGA 196 56.63a
Without MGA 133 36.84b
Total 534 53.18
(1)Values followed by the same letter do not differ by chi-square test, at 5% 
probability. The supplementation with MGA was done between 13 and 18 
days after insemination. 
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the beginning of the protocol had higher conception 
rates (55.5%) than did animals that had only ≥8 mm 
follicles (34.4%), or those that had only <8 mm follicles 
(29.4%), which led to a difference in the response to 
the synchronization protocol, according to the prior 
ovarian conditions of the animals.
Following this same line of research, Pugliesi et 
al. (2016) tested the supplementation with another 
source of P4 (long-acting injectable), four days after 
ovulation, and measured the conception rates of 
Nellore females in TAI programs. These authors did 
not find a significant effect of this treatment when 
it was applied to animals with unknown ovarian 
conditions (anestrus or cycling). However, when 
the same treatment was performed only in lactating 
cows in anestrus, at the beginning of the protocol, the 
conception rates improved significantly.
Several studies have reported a high percentage of 
animals in anestrus, at the beginning of the protocol, 
in herds of lactating Zebu cows reared on pasture. 
Baruselli et al. (2002) found a low percentage (14.0%) 
of lactating beef cows cycling between 60 and 70 days 
postpartum, and, according to Wheaton et al. (2007), 
in grazing systems, suckling beef cows at 30 to 40 
days postpartum can show anestrus rate of up to 90%, 
at which point they are included in TAI programs. 
Thus, the use of strategies that enable better results in 
this group of animals, as proposed in this experiment, 
is an alternative for improving the fertility of beef 
cows in large breeding systems in Brazil, and may be 
a practical alternative that does not require additional 
management.
When considering the interaction of the treatment 
with the estrus expression of the animals, there was 
a positive effect of the MGA administration between 
the 13th and 18th day after TAI on the conception 
rate of Nellore cows, regardless of estrus expression 
(Table 3). As to the interaction of the treatment with 
MGA and POFD on the conception rate of the animals, 
no significant effect of the treatment was found on the 
animals with POFD <11 mm and DFOL between 11 
and 14 mm. However, the animals with POFD >14 
mm had better conception rates when supplemented 
with MGA between days 13 and 18 after insemination, 
in comparison with the nonsupplemented animals 
(Table 4).
According to Ferraz et al. (2017), Zebu females that 
were subjected to TAI programs and were expressing 
estrus during the protocol (between removal of the 
intravaginal device and the time of insemination) 
had a higher conception rate than animals that were 
not in estrus. Similarly, animals with larger follicle 
diameters at the time of insemination were more likely 
to become pregnant than those with follicles that had 
smaller diameters (Ribeiro Filho et al., 2013).
These satisfactory results for the conception 
rate of the animals observed in estrus during the 
synchronization protocol, and with animals that had 
larger follicles at the time of TAI, promoted a gene 
expression profile in reproductive tissues during the 
Table 3. Conception rate and estrus expression of Nellore 
cows subjected to a TAI protocol, with and without the use 
of 0.5 mg per day of melengestrol acetate (MGA)(1).
Treatment Number of animals Conception rate (%)
Expressing estrus
With MGA 168 68.45a
Without MGA 104 52.88b
Without estrus
Anestrus with MGA 158 48.10b
Anestrus without MGA 104 36.54c
Total 534 53.18
(1)Values followed by the same letter do not differ by chi-square test, at 5% 
probability. The supplementation with MGA was done between 13 and 18 
days after insemination.
Table 4. Conception rate and diameter of the largest 
follicle at the time of insemination (POFD) of Nellore cows 
subjected to TAI program, with and without  the use of 0.5 
mg per day of melengestrol acetate (MGA)(1).
Treatment Number of animals Conception rate (%)
POFD <11 mm
With MGA 109 44.04c
Without MGA 79 40.51c
POFD = 11–14 mm
With MGA 124 62.90ab
Without MGA 85 50.59bc
POFD >14 mm
With MGA 93 69.89a
Without MGA 44 40.91c
Total 534 53.18
(1)Values followed by the same letter do not differ by chi-square test, at 5% 
probability. The supplementation with MGA was done between 13 and 18 
days after insemination.
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preimplantation phase, and provided an adequate 
uterine environment for conception (Davoodi et al., 
2016). Furthermore, adequate concentrations of E2 
during the final follicular growth were positively 
correlated with the preovulatory follicle diameter and 
luteal function, which facilitated the establishment 
and maintenance of pregnancy (Bridges et al., 2012; 
Stevenson & Lamb, 2016).
Based on this positive association between the 
circulating concentration of E2, at the time of 
insemination, and the serum P4 levels after ovulation 
which favors conception rates as shown by Atkins et 
al. (2013), the hypothesis can be proposed that animals 
with smaller preovulatory follicles, and that do not 
express heat, would have better results with MGA. 
However, under the conditions of this experiment, this 
effect was not confirmed.
Treatment with MGA significantly affected the 
conception rate of the groups, independently of estrus 
expression, and it was not effective on animals with 
small (<11 mm) or medium (11 to 14 mm) follicles.
Conclusions
1. The treatment with MGA is effective for 
improving the conception rate of multiparous lactating 
Nellore cows in TAI programs, especially in anestrus 
animals, which means that it is possible to establish 
strategies for providing MGA, depending on the 
ovarian conditions of the animals.
2. Estrus expression and preovulatory follicle 
diameter are not effective as predictors for selecting 
animals to be supplemented with MGA.
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